Critically, this novel mechanism could operate in autoimmune diseases, where GLUT4 is reduced in patients with autoinflammatory myopathies, coinciding with overexpression of RLRs and interferon stimulated genes (ISGs). The gene discussed is SLC2A4; the disease is autoimmune disease.